New updates in Drug Formulation & Bioavailability

September 1st | Copenhagen

Welcome to the 9th edition of our event
New updates in Drug Formulation & Bioavailability.

Moderator: Korbinian Löbmann,
Associate Professor University of Copenhagen

This event is a platform based on the concept of synergies between "science" and "business". Meet R&D people, the pharma industry, increase your awareness and gain more knowledge about this exciting topic.

The presented content and topics will focus on advancements in formulations and cutting edge technologies that can allow cheaper, safer and effective drugs. Pharmaceutical formulation can have a huge impact on the bioavailability of a given drug and is one of the key factors in the successful development of drug delivery systems.

However, many of the APIs in the development pipelines often possess poor physico-chemical properties, which make them difficult to formulate using classic approaches and hence require the use of new and enabling formulation approaches.

The meeting will include pre-bookable face-to-face-meetings and will be covered by the media.

Topics will include:

Formulation development design space
Improving bioavailability of poorly soluble compounds
Controlled and modified release technologies
Out-sourcing and in-licensing
Exploring different routes of administration in enhancing macromolecule delivery

The target audience consists of:

Drug formulation professionals from Big Pharma, CDMO's, Academia
Early Phase & virtual biotech and pharma companies
QA & Reg Aff. Managers
Procurement Managers
Speakers will come from: Pharmaceutical companies, Excipient manufacturers, CDMO's, Academia

Partners

Organizer

In collaboration with